Literature DB >> 16474416

Species-dependent smooth muscle contraction to Neuromedin U and determination of the receptor subtypes mediating contraction using NMU1 receptor knockout mice.

Clodagh E Prendergast1, Magda F Morton, Katherine W Figueroa, Xiaodong Wu, Nigel P Shankley.   

Abstract

The peptide ligand neuromedin U (NMU) has been implicated in an array of biological activities, including contraction of uterine, intestinal and urinary bladder smooth muscle. However, many of these responses appear to be species-specific. This study was undertaken to fully elucidate the range of smooth muscle-stimulating effects of NMU in rats, mice and guinea-pigs, and to examine the extent of the species differences. In addition, the NMU1 receptor knockout mouse was used to determine which receptor subtype mediates the contractile responses generated by NMU in the mouse. A range of isolated organ in vitro bioassays were carried out, which were chosen to re-confirm previous literature reports (uterine and stomach fundus contraction) and also to explore potentially novel smooth muscle responses to NMU. This investigation uncovered a number of previously unidentified NMU-mediated responses: contraction of rat lower esophageal sphinster (LES), rat ileum, mouse gallbladder, enhancement of electrically evoked contractions in rat and mouse vas deferens, and a considerable degree of cross-species differences. Studies using the NMU1 receptor knockout mice revealed that in the mouse fundus and gallbladder assays the NMU contractile response was mediated entirely through the NMU1 receptor subtype, whereas, in assays of mouse uterus and vas deferens, the response to NMU was unchanged in the NMU1 receptor knockout mouse, suggesting that the NMU response may be mediated through the NMU2 receptor subtype. NMU receptor subtype-selective antagonists are required to further elucidate the role of the individual receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16474416      PMCID: PMC1760708          DOI: 10.1038/sj.bjp.0706677

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

1.  Distribution and characterisation of neuromedin U-like immunoreactivity in rat brain and intestine and in guinea pig intestine.

Authors:  S J Augood; J R Keast; P C Emson
Journal:  Regul Pept       Date:  1988-04

2.  beta(1)-Adrenoceptors compensate for beta(3)-adrenoceptors in ileum from beta(3)-adrenoceptor knock-out mice.

Authors:  D S Hutchinson; B A Evans; R J Summers
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

3.  The motor effect of neuromedin U on rat stomach in vitro.

Authors:  M A Benito-Orfila; J Domin; K A Nandha; S R Bloom
Journal:  Eur J Pharmacol       Date:  1991-02-14       Impact factor: 4.432

4.  Identification of receptors for neuromedin U and its role in feeding.

Authors:  A D Howard; R Wang; S S Pong; T N Mellin; A Strack; X M Guan; Z Zeng; D L Williams; S D Feighner; C N Nunes; B Murphy; J N Stair; H Yu; Q Jiang; M K Clements; C P Tan; K K McKee; D L Hreniuk; T P McDonald; K R Lynch; J F Evans; C P Austin; C T Caskey; L H Van der Ploeg; Q Liu
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

5.  Signaling and ligand binding by recombinant neuromedin U receptors: evidence for dual coupling to Galphaq/11 and Galphai and an irreversible ligand-receptor interaction.

Authors:  Paul J Brighton; Philip G Szekeres; Alan Wise; Gary B Willars
Journal:  Mol Pharmacol       Date:  2004-08-26       Impact factor: 4.436

6.  Structure-activity relationships of rat neuromedin U for smooth muscle contraction.

Authors:  N Sakura; S Ohta; Y Uchida; K Kurosawa; K Okimura; T Hashimoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1991-08       Impact factor: 1.645

7.  Primary structure of neuromedin U from the rat.

Authors:  J M Conlon; J Domin; L Thim; V DiMarzo; H R Morris; S R Bloom
Journal:  J Neurochem       Date:  1988-09       Impact factor: 5.372

8.  Regional hemodynamic effects of neuromedin U in conscious rats.

Authors:  S M Gardiner; A M Compton; T Bennett; J Domin; S R Bloom
Journal:  Am J Physiol       Date:  1990-01

9.  Hypothalamic actions of neuromedin U.

Authors:  A M Wren; C J Small; C R Abbott; P H Jethwa; A R Kennedy; K G Murphy; S A Stanley; A N Zollner; M A Ghatei; S R Bloom
Journal:  Endocrinology       Date:  2002-11       Impact factor: 4.736

Review 10.  Neuromedin U and its receptors: structure, function, and physiological roles.

Authors:  Paul J Brighton; Philip G Szekeres; Gary B Willars
Journal:  Pharmacol Rev       Date:  2004-06       Impact factor: 25.468

View more
  7 in total

1.  Neuromedin U can exert colon-specific, enteric nerve-mediated prokinetic activity, via a pathway involving NMU1 receptor activation.

Authors:  N B Dass; A K Bassil; V J North-Laidler; R Morrow; E Aziz; B R Tuladhar; G J Sanger
Journal:  Br J Pharmacol       Date:  2007-01-08       Impact factor: 8.739

2.  Comparative analysis of myometrial and vascular smooth muscle cells to determine optimal cells for use in drug discovery.

Authors:  Shajila Siricilla; Kelsi M Knapp; Jackson H Rogers; Courtney Berger; Elaine L Shelton; Dehui Mi; Paige Vinson; Jennifer Condon; Bibhash C Paria; Jeff Reese; Quanhu Sheng; Jennifer L Herington
Journal:  Pharmacol Res       Date:  2019-05-09       Impact factor: 7.658

3.  The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation.

Authors:  Antonia Wallrapp; Samantha J Riesenfeld; Patrick R Burkett; Raja-Elie E Abdulnour; Jackson Nyman; Danielle Dionne; Matan Hofree; Michael S Cuoco; Christopher Rodman; Daneyal Farouq; Brian J Haas; Timothy L Tickle; John J Trombetta; Pankaj Baral; Christoph S N Klose; Tanel Mahlakõiv; David Artis; Orit Rozenblatt-Rosen; Isaac M Chiu; Bruce D Levy; Monika S Kowalczyk; Aviv Regev; Vijay K Kuchroo
Journal:  Nature       Date:  2017-09-13       Impact factor: 49.962

Review 4.  Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S.

Authors:  J D Mitchell; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2009-06-10       Impact factor: 8.739

5.  The neuropeptide neuromedin U promotes autoantibody-mediated arthritis.

Authors:  Sindhuja M Rao; Jennifer L Auger; Philippe Gaillard; Ralph Weissleder; Etsuko Wada; Richard Torres; Masayasu Kojima; Christophe Benoist; Diane Mathis; Bryce A Binstadt
Journal:  Arthritis Res Ther       Date:  2012-02-07       Impact factor: 5.156

Review 6.  Regulation of immune responses by the airway epithelial cell landscape.

Authors:  Richard J Hewitt; Clare M Lloyd
Journal:  Nat Rev Immunol       Date:  2021-01-13       Impact factor: 108.555

7.  Uterotonic Neuromedin U Receptor 2 and Its Ligands Are Upregulated by Inflammation in Mice and Humans, and Elicit Preterm Birth.

Authors:  Mathieu Nadeau-Vallée; Amarilys Boudreault; Kelycia Leimert; Xin Hou; Dima Obari; Ankush Madaan; Raphaël Rouget; Tang Zhu; Lydia Belarbi; Marie-Ève Brien; Alexandra Beaudry-Richard; David M Olson; Sylvie Girard; Sylvain Chemtob
Journal:  Biol Reprod       Date:  2016-08-10       Impact factor: 4.285

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.